His Excellency Mr. Philippe Geux, the Ambassador of Switzerland to the Czech Republic, toured the Plant Tissue Culture facility of Genetia BioSciences on Monday, June 13. The Ambassador was accompanied by Mrs. Soňa Kritzlerová of the Swiss Embassy, Ing. Petr Kalaš, former Czech Minister of the Environment, and Petr Kotal, Ph.D., DSc., Honorary Consul for the Czech Republic in Lausanne, Switzerland, and CEO of Prague Innovation Centre.
Ambassador Philippe Geux (l) is welcomed to the Prague Innovation Centre by its CEO Petr Kotal (r)
The visit highlighted the strong cooperation between Genetia BioSciences and its Swiss partner on CleanTech technology utilized for the mass production of in vitro plants. Specifically, cannabis and hemp varieties represent ideal multi-purpose, highly circular crops that facilitate uses in the circular and biobased economy. All the derivatives from the whole plant are disposable, reusable, or biodegradable. The commercial potential of the more than 600 plant constituents is enormous. The numerous applications are found in medicines, food, bioplastics, fuels, bio composite, building materials, animal feed, paper, cosmetics, and nutraceuticals.
Invitro plant material at Genetia Cleanlabs
Introduction to Plant Tissue Culture processes at Genetia Cleanlabs. From right to left, Ambassador Geux, Dr. Kotal, Mrs. Kritzlerová, and Ing. Kalaš
Beyond plant tissue culture
Located in the Prague Innovation Centre: InnoCrystal, with its roots in The Netherlands, Genetia BioSciences is a leading biotech company active in the field of Plant Tissue Culture and Advanced Molecular Breeding Technology. With a strong in-house R&D, well connected to academia, and with years of market experience, it integrates the latest developments in plant sciences, cleantech technology, and best practices to create a value-added product for its clients that goes beyond pathogen-free starting material.
The delegations from the Swiss Embassy, Prague Innovation Centre, and Genetia BioSciences
Genetia and the Swiss company Puregene AG, a market leader in next-generation molecular plant breeding technology, are collaborating on molecular plant pathogen detection and diagnostics. The companies seek to intensify the further development of in vitro mass production and breeding services in the Czech Republic. The success formula is the combination of Swiss precision, Dutch ingenuity, and Czech enterprise in a favorable business and legislative climate in the Czech Republic.